Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study. In the 18-month trial
Share this article
If you liked this article share it with your friends.they will thank you later
/newsdrum-in/media/media_files/Hf68R5EH10UIvnjxdGKA.jpg)
1 Min read
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg){kind=logo}
